Video

Howard Weintraub, MD, on Useful Patient Prognoses to Address Diabetes

Author(s):

The New York University clinical professor of medicine also shared his thoughts on the future of cardiovascular disease medicine.

Howard Weintraub, MD, has found there's particular words that get through to patients struggling with obesity.

"When you say the word diabetes, everybody knows somebody who has been amputated, who's had a stroke or an MI, or even multiple ones and have become invalid," Weintraub, a clinical professor at New York University, said.

The anecdotal fear that a patient associates with such potential diseases is also why Weintraub doesn't hesistate from diagnosing pre-diabetes in his patients, either.

In an interview with MD Magazine, Weintraub sat down to explain this train of thinking, as well as what he thinks the future of cardiovascular disease treatment will look like.

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.